A collaborative U-M team shows that liver injury is less likely to originate from popular cancer immunotherapy drug, pembrolizumab, than tumor progression.
Liver Conditions & Procedures
U-M researchers identify a potential treatment for non-alcoholic fatty liver disease.
An enzyme’s newly discovered ability to spur the body to prevent or repair acute liver injury in mice could be harnessed as a therapy or used as a biomarker.<
A recent paper from two U-M hepatologists highlights the liver dangers associated with consuming some herbal and dietary supplements designed to build muscle or lose weight.
A cutting-edge imaging strategy could significantly improve survival rates among patients at risk for liver cancer.
Rapid rise in liver deaths highlights new challenges in treatment and prevention despite gains in fighting hepatitis C, researchers say.